Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Of course you want a CR, or, the most possible response. But you cannot always get what you want, as the song goes. These are patients that have failed other treatments.

If K at this dosing is helpful then what about 3x week or 5 x week?

Let's say still no better than stabilization- still means K can be tossed into the mix with other regimens.

Go look at the Aspire data on their p53 drug plus Cisplat for refractory ovarian CA- addition of their p53 drug made a big difference in the lab- who knows in patients.

K plus sunitinib for renal, K plus other for AML- that is the future. Or K plus immunotherapy, everybody's favorite new approach.(unless K really is an effective single agent for ovarain, we shall see)

You obv have some science knowledge. Sure, it may take years to play out; but this is still very good news